Company: SRPT
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029973
Chunk: 498

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-02-28
Form: 10-K
Item: Item 8
Chunk 498
---
8-K
     
    001-14895
     
    10.3
     
    6/28/17

     10.16†
     
    Restricted Stock Agreement under the 2014 Employment Commencement Incentive Plan 
     
    8-K
     
    001-14895
     
    10.4
     
    6/28/17

     10.17†
     
    Performance Stock Option Award Agreement under the 2014 Employment Commencement Incentive Plan
     
    8-K
     
    001-14895
     
    10.5
     
    6/28/17

     10.18*
     
    Settlement Agreement between Sarepta Therapeutics, Inc., Sarepta International C.V. and The University of Western Australia on the one hand, and BioMarin Leiden Holding BV, BioMarin Nederlands BV and BioMarin Technologies BV on the other hand dated July 17, 2017
     
    10-Q
     
    001-14895
     
    10.7
     
    8/3/17

-87-

     10.19*
     
    License Agreement between Sarepta Therapeutics, Inc. and Sarepta International C.V. on the one hand and BioMarin Leiden Holding BV, BioMarin Nederlands BV and BioMarin Technologies BV on the other hand dated July 17, 2017 
     
    10-Q
     
    001-14895
     
    10.8
     
    8/3/17

     10.20
     
    Base Call Option Transaction Confirmation, dated as of September 13, 2022, between Sarepta Therapeutics, Inc. and Barclays Bank PLC.
     
    8-K
     
    001-14895
     
    10.3
     
    9/19/22

     10.21
     
    Base Call Option Transaction Confirmation, dated as of September 13, 2022, between Sarepta Therapeutics, Inc. and Goldman Sachs & Co. LLC.
     
    8-K
     
    001-14895
     
    10.4
     
    9/